TAK

Takeda Pharmaceutical Co Ltd

Healthcare · Drug Manufacturers - Specialty & Generic

17.40$ -0.1% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Balance Sheet

Takeda Pharmaceutical Co Ltd (TAK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 15,663,271 million JPY. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of JPY.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TAK
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	3,801,817	4,142,032	4,355,782	4,345,922	4,375,955	4,410,558	4,106,463	4,159,577	4,274,839	5,767,223	13,872,322	13,550,424	12,880,141	13,031,494	12,821,094	12,613,852	12,414,747	12,286,137	12,912,293	12,657,234	12,560,273	12,698,519	13,178,018	14,065,426	14,588,847	13,504,705	13,957,750	14,792,738	14,871,889	14,222,947	15,108,792	16,227,683	14,573,000	15,106,844	14,248,344	14,004,537	14,470,300	15,419,293	15,520,136	15,663,271
Current Assets	1,484,302	1,656,260	1,260,662	1,270,818	1,221,996	1,265,978	1,078,808	1,043,548	1,107,943	2,670,072	3,050,658	2,932,156	2,374,440	2,520,325	2,469,432	2,474,763	2,585,136	2,616,598	2,712,893	2,476,458	2,456,353	2,477,893	2,593,642	2,549,515	2,745,616	2,595,946	2,397,956	2,472,017	2,462,066	2,428,830	2,558,580	3,107,532	3,054,013	2,754,287	2,521,192	2,513,122	2,920,620	3,118,566	3,103,907	3,150,269
Cash	619,144	559,166	319,455	432,302	430,895	440,253	294,522	231,480	317,080	297,873	702,093	593,745	543,517	568,279	637,614	589,787	630,868	617,635	966,222	654,920	607,881	724,341	849,695	645,991	798,137	685,141	533,530	316,380	318,051	288,359	457,800	804,272	859,015	494,126	385,113	350,008	681,486	655,384	597,635	460,982
Cash & Short-Term Investments	739,176	738,447	376,138	490,281	460,666	466,480	375,168	250,627	337,361	1,864,203	725,369	615,087	557,433	588,423	653,436	600,925	646,182	654,299	1,002,820	684,850	633,623	751,896	875,000	664,534	830,069	726,608	553,704	368,609	333,807	317,404	472,889	857,658	906,215	526,747	405,589	419,175	739,678	761,941	597,635	527,582
Receivables	446,199	496,864	444,778	471,163	470,857	518,685	428,792	459,715	468,919	515,791	749,119	788,629	805,737	852,128	784,921	815,271	769,806	828,942	812,714	858,957	887,295	756,117	724,378	794,092	800,536	779,872	681,694	825,481	788,066	743,079	697,610	772,367	721,056	735,064	725,254	679,531	702,238	758,438	880,149	956,140
Inventory	237,923	222,910	226,294	234,679	234,300	225,101	212,944	221,424	233,304	223,398	986,744	902,522	840,840	801,341	759,599	759,378	743,482	739,352	753,881	779,148	783,476	811,324	853,167	927,511	953,450	927,286	986,457	1,083,374	1,155,866	1,169,640	1,209,869	1,276,739	1,206,431	1,246,427	1,217,349	1,240,676	1,299,486	1,408,153	1,402,677	1,447,259
Property, Plant & Equipment	–	–	–	–	–	4,808	5,069	4,763	4,679	5,492	1,316,531	1,481,113	1,457,060	1,468,842	1,386,370	1,366,177	1,366,950	1,363,141	1,453,917	1,452,172	1,459,919	1,493,587	1,582,800	1,705,367	1,760,327	1,656,416	1,691,229	1,795,315	1,894,136	–	–	–	1,887,620	2,017,776	1,968,209	1,956,269	1,984,126	2,083,981	–	–
Goodwill	697,261	777,344	1,022,711	1,052,983	1,072,962	1,078,236	1,029,248	1,053,998	1,085,706	1,053,506	4,161,403	4,064,572	4,029,507	4,104,150	4,012,528	3,984,271	3,856,147	3,824,804	4,033,917	4,058,935	4,078,369	4,167,993	4,407,749	4,813,610	4,994,632	4,690,949	4,790,723	5,182,128	5,301,017	5,111,287	5,410,067	5,733,710	5,160,112	5,522,112	5,324,430	5,295,871	5,431,698	5,757,195	5,834,205	5,886,905
Intangible Assets	608,537	684,861	1,065,835	1,055,752	1,092,637	1,073,469	1,014,264	1,057,985	1,067,172	1,020,216	4,860,368	4,580,341	4,425,199	4,308,394	4,171,361	4,043,156	3,878,257	3,756,723	3,909,106	3,856,432	3,783,677	3,791,875	3,818,544	4,145,090	4,187,055	3,765,757	4,269,657	4,514,084	4,402,421	4,097,022	4,274,682	4,366,147	3,770,620	3,952,039	3,631,560	3,422,542	3,299,225	3,518,028	3,434,178	3,391,152
Total Liabilities	1,922,774	2,097,623	2,406,817	2,309,139	2,270,258	2,276,475	2,089,054	2,093,003	2,102,678	3,724,645	8,708,734	8,675,973	8,010,457	8,155,275	8,093,608	7,923,088	7,748,248	7,646,709	7,735,116	7,418,591	7,235,912	7,366,696	7,494,495	7,748,043	7,875,358	7,328,207	7,603,079	7,871,069	7,800,864	7,480,340	7,834,787	8,428,450	7,651,403	7,687,653	7,312,365	7,138,357	7,338,611	7,769,983	7,711,616	8,104,395
Current Liabilities	808,837	957,948	1,366,091	939,624	838,769	878,170	737,509	733,444	844,192	871,707	2,510,931	2,006,623	1,634,634	2,127,365	2,175,898	2,031,544	1,709,661	1,804,958	1,773,176	1,706,782	1,918,750	1,809,254	2,145,730	2,166,942	2,391,720	2,236,809	2,481,940	2,501,741	2,367,617	2,282,168	2,313,103	2,465,202	2,387,237	2,097,964	2,506,521	2,169,586	2,139,655	2,611,965	2,440,067	2,764,547
Short-Term Debt	211,467	235,844	545,028	203,635	139,989	140,000	18	1,185	120,913	120,743	984,946	520,665	171,391	611,701	586,817	580,732	276,616	284,474	22,153	24,272	214,886	122,936	203,993	281,897	568,228	372,019	339,600	416,860	274,841	370,292	367,251	438,743	624,101	135,467	548,939	371,143	293,858	583,545	514,378	519,970
Accounts Payable	196,877	231,832	240,623	219,633	209,677	223,452	133,705	225,492	225,752	248,616	212,348	278,886	280,409	299,892	211,627	289,741	272,778	326,978	232,105	320,645	336,600	351,185	295,934	424,358	388,616	381,109	307,453	440,924	421,078	483,666	319,955	468,882	413,335	460,181	308,450	421,308	438,985	467,913	493,476	446,784
Long-Term Debt	–	–	–	–	–	8,863	9,308	8,962	7,721	22,159	4,766,005	5,131,983	4,853,219	4,610,052	4,506,487	4,494,225	4,631,418	4,466,574	4,613,218	4,381,589	4,016,473	4,231,939	4,141,418	4,320,357	4,168,417	3,914,884	4,042,741	4,330,254	4,404,363	4,293,872	4,476,501	5,042,242	4,427,092	4,704,681	3,966,326	4,134,799	4,351,462	4,270,174	4,369,681	4,419,998
Shareholders' Equity	1,819,158	1,981,581	1,894,261	2,014,570	2,085,734	2,113,885	1,997,424	2,043,500	2,168,358	2,038,682	5,159,582	4,870,365	4,865,714	4,872,072	4,723,483	4,686,763	4,662,402	4,635,353	5,173,037	5,238,258	5,323,935	5,331,330	5,683,019	6,316,832	6,712,929	6,175,978	6,354,122	6,921,052	7,070,352	6,741,934	7,273,264	7,798,417	6,920,754	7,418,274	6,935,084	6,865,259	7,130,697	7,648,160	7,807,307	7,557,887
Retained Earnings	1,573,629	1,546,995	1,511,817	1,586,328	1,614,365	1,609,841	1,557,307	1,593,297	1,648,094	1,614,904	1,569,365	1,405,026	1,477,589	1,378,447	1,369,972	1,330,054	1,337,065	1,306,568	1,509,906	1,503,811	1,551,150	1,466,926	1,479,716	1,459,764	1,530,200	1,507,720	1,541,146	1,490,097	1,446,018	1,396,838	1,391,203	1,338,192	1,431,684	1,290,948	1,187,586	1,156,692	1,148,658	1,096,410	1,061,114	667,007
Shares Outstanding	1,568	1,569	1,562	1,570	1,572	1,573	1,563	1,573	1,575	1,577	3,137	3,122	3,124	3,115	3,115	3,132	3,146	3,151	3,147	3,109	3,161	3,150	3,152	3,109	3,127	3,141	3,228	3,130	3,131	3,170	3,137	3,178	3,220	3,170	3,163	3,176	3,155	3,205	3,125	3,209

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Balance Sheet

Cookie settings